Pharmaceutical precautions: Any unused solutions should be discarded.
The solution is to be visually inspected prior to use. Only clear solutions practically free from particles should be used.
Rocuronium has shown to be compatible with: sodium chloride 9 mg/ml (0.9 %) and glucose 50 mg/ml (5 %) solution for infusion.
If rocuronium bromide is administered via the same infusion line with other medicinal products, it is important that the infusion line is adequately flushed (e.g. with sodium chloride 9 mg/ml (0.9 %) solution for infusion) between administration of rocuronium bromide and medicinal products for which incompatibility with rocuronium bromide has been demonstrated or for which compatibility with rocuronium bromide has not been established.
Any unused product or waste material should be disposed of in accordance with local requirements.
Incompatibilities: Physical incompatibility has been documented for rocuronium bromide when added to solutions containing the following active substances: amphotericin, amoxicillin, azathioprine, cefazolin, cloxacillin, dexamethasone, diazepam, enoximone, erythromycin, famotidine, furosemide, hydrocortisone sodium succinate, insulin, intralipid, methohexital, methylprednisolone, prednisolone sodium succinate, thiopental, trimethoprim and vancomycin.
This medicinal product must not be mixed with other medicinal products except those previously mentioned in Pharmaceutical precautions.